- Home
- KLTO vs IMCC Comparison
KLTO vs IMCC Comparison
Compare KLTO & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLTO
- IMCC
- Stock Information
- Founded
- KLTO 2019
- IMCC 1980
- Country
- KLTO United States
- IMCC Israel
- Employees
- KLTO N/A
- IMCC N/A
- Industry
- KLTO
- IMCC Medicinal Chemicals and Botanical Products
- Sector
- KLTO
- IMCC Health Care
- Exchange
- KLTO NYSE
- IMCC Nasdaq
- Market Cap
- KLTO 5.9M
- IMCC 5.3M
- IPO Year
- KLTO N/A
- IMCC N/A
- Fundamental
- Price
- KLTO $0.71
- IMCC $2.65
- Analyst Decision
- KLTO
- IMCC
- Analyst Count
- KLTO 0
- IMCC 0
- Target Price
- KLTO N/A
- IMCC N/A
- AVG Volume (30 Days)
- KLTO 84.5M
- IMCC 465.6K
- Earning Date
- KLTO 08-15-2025
- IMCC 08-13-2025
- Dividend Yield
- KLTO N/A
- IMCC N/A
- EPS Growth
- KLTO N/A
- IMCC N/A
- EPS
- KLTO N/A
- IMCC N/A
- Revenue
- KLTO N/A
- IMCC $37,894,737.00
- Revenue This Year
- KLTO N/A
- IMCC $47.12
- Revenue Next Year
- KLTO N/A
- IMCC $12.83
- P/E Ratio
- KLTO N/A
- IMCC N/A
- Revenue Growth
- KLTO N/A
- IMCC 12.68
- 52 Week Low
- KLTO $0.11
- IMCC $1.29
- 52 Week High
- KLTO $3.91
- IMCC $7.12
- Technical
- Relative Strength Index (RSI)
- KLTO N/A
- IMCC 50.26
- Support Level
- KLTO N/A
- IMCC $2.67
- Resistance Level
- KLTO N/A
- IMCC $3.35
- Average True Range (ATR)
- KLTO 0.00
- IMCC 0.40
- MACD
- KLTO 0.00
- IMCC -0.05
- Stochastic Oscillator
- KLTO 0.00
- IMCC 33.94
About KLTO KLOTHO NEUROSCIENCES INC
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.